Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512 ·Status: ACTIVE_NOT_RECRUITING

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

NCT00897910 ·Status: TERMINATED

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

NCT06140524 ·Status: RECRUITING ·Phase: PHASE2

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

NCT06151717 ·Status: COMPLETED

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

NCT05271630 ·Status: ACTIVE_NOT_RECRUITING

Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma

NCT00185653 ·Status: COMPLETED ·Phase: NA

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

NCT06630104 ·Status: RECRUITING ·Phase: NA

Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients

NCT06457464 ·Status: NOT_YET_RECRUITING

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT00995059 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma

NCT04036461 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma

NCT02561962 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

NCT05336383 ·Status: RECRUITING ·Phase: PHASE2

Multiple Myeloma Patient Registry

NCT03180853 ·Status: TERMINATED

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

NCT01234129 ·Status: COMPLETED

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

NCT00721734 ·Status: COMPLETED ·Phase: PHASE2

PRospective Multiple Myeloma Impact Study

NCT02911571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients

NCT03464916 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

NCT00036140 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies

NCT02997813 ·Status: COMPLETED

Etiology of Multiple Myeloma: A Case-Control Study

NCT00505999 ·Status: UNKNOWN

Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma

NCT00567229 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

NCT01965834 ·Status: TERMINATED ·Phase: PHASE2

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

NCT05090566 ·Status: TERMINATED ·Phase: PHASE2

A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma

NCT01025206 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

NCT03127761 ·Status: RECRUITING